ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Exosomal TGFbeta:LAP as Immunosuppressive Mediator of Allo-Tolerance

W. Burlingham1, E. Jankowska-Gan2, J. Fechner3, C. Little2, J. Sullivan4, D. Foley1

1University of Wisconsin, Madison, WI, 2Surgery-Transplant Division, University of Wisconsin, Madison, WI, 3Surgery-Transplant Division, University of Wisconsin-Madison, Madison, WI, 4Surgery, University of Wisconsin, Madison, WI

Meeting: 2022 American Transplant Congress

Abstract number: 1261

Keywords: Alloantigens, Graft acceptance, Mice, Tolerance

Topic: Basic Science » Basic Science » 10 - Treg/Other Regulatory Cell/Tolerance

Session Information

Session Name: Treg/Other Regulatory Cell/Tolerance

Session Type: Poster Abstract

Date: Monday, June 6, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: TGFβ has long been known as a key component in tolerance mediated by Treg cells. Here we show that, unlike IL10, but like CD39/CD73, and the immune-suppressive cytokine IL35, TGFβ produced by allo-specific Tregs was associated with small EV in its latent precursor form (TGFβ /LAP). We investigated the role of small extracellular vesicles (sEV), aka exosomes, in the regulation mediated by T- and B-regs after induction of allo-tolerance. We wished to test the hypothesis that LAP-TGFβ1 was tethered to exosomes produced by T- and B-regs, and could be activated, once these sEV were taken up by conventional T cells, suppressing the local immune response.

*Methods: C57BL/6 mice were tolerized by i.p. injection of CBA/J splenocytes combined with anti-CD40L/CD154 antibody treatment on d. 0,2,&4. At d. 35, spleen and LNs were harvested and SC and LNC were cultured with x-irradiated CBA SC overnight. sEV/exosomes were harvested from plasma and from culture supernatants by ultracentrifugation (100,000 xg) and assayed for 10 and 20 immunosuppression of TT-immunized B6 splenocytes using trans-vivo DTH assay, and for acquisition of TGFβ/LAP and TGFβRIII by flow cytometry.

*Results: We found that, after tolerization induced T& B reg cells secreted TGFb/LAP-coated EV, which was mainly associated with CD81+ exosomes.Like CD81-bound IL35, EV-TGFβ became active in BOTH 10 and 20 immunosuppression, the latter being the ability to impart suppression capacity to “naïve” lymphocytes. Small EV/exosomes produced by T & Bregs induced by, and tolerant to, MHC and non-MHC/minor Ags mediate tolerance via TGFβ in 2 major ways— a) In 10 suppression, by directly interfering with T effector functions, &b) In 20 suppression, by uptake and passive surface re-expression of EV components by bystander T cells, which then suppress as “surrogates”

*Conclusions: Like other suppressive components of the Treg exosome which are bound in a latent form, TGFβ/LAP requires processing to become the profoundly suppressive agent of allo-tolerance produced by allo-specific regulatory T cells. We are currently analyzing various mechanisms that might account for tethering the secreted TGFβ/LAP to exosomes.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Burlingham W, Jankowska-Gan E, Fechner J, Little C, Sullivan J, Foley D. Exosomal TGFbeta:LAP as Immunosuppressive Mediator of Allo-Tolerance [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/exosomal-tgfbetalap-as-immunosuppressive-mediator-of-allo-tolerance/. Accessed May 28, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences